Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1997;4(4):193–197. doi: 10.1155/MBD.1997.193

Di-n-Butyl-, Tri-n-Butyl- and Triphenyltin dl-Terebates: Synthesis, Characterization and In Vitro Antitumour Activity

Marcel Gielen 1, Huairang Ma 1,3, Abdeslam Bouhdid 1, Hassan Dalil 1, Monique Biesemans 1,2, Rudolph Willem 1,2
PMCID: PMC2365070  PMID: 18475788

Abstract

Di-n-butyltin, tri-n-butyltin and triphenyltin terebates were screened against several human tumour cell lines and found comparably or more active than carboplatin, cis-platin, 5-fluorouracil, methotrexate and doxorubicin, some reference compounds used clinically.

Full Text

The Full Text of this article is available as a PDF (657.1 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES